| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.058 | 0.08 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.088 | 0.08 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.08 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.065 | 0.09 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.052 | 0.09 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.27 | 0.09 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.21 | 0.09 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.09 |